Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation
Precision Clinical Medicine · 11.04.2026 · 9 (2)
DOI: 10.1093/pcmedi/pbag011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 27.03.2026. Verfasst von Nan Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto M4N 3M5, Canada. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lotte and John Hecht Memorial Foundation.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are a class of endogenous non-coding RNAs characterized by a covalently closed-loop structure. Although initially regarded as splicing byproducts, circRNAs are now recognized as essential regulators of gene and protein expression and play important roles in various human diseases. In recent years, growing evidence has indicated that a subset of circRNAs can be translated through cap-independent mechanisms to produce bioactive peptides or proteins. These findings expand the functional scope of circRNAs and offer new opportunities for RNA therapy. This review summarizes recent advances in circRNA biology, with an emphasis on their potential in diagnosis and treatment. We also review the therapeutic strategies targeting circRNAs at both the RNA and protein levels and the delivery systems that support circRNA-directed therapies. After we discuss how circRNA therapeutics may be integrated into precision medicine, we further highlight the current clinical progress and key challenges for advancing circRNA-based therapies toward clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto M4N 3M5, Canada.
- Human Biology Program, University of Toronto, 149 College Street, Toronto M5S 3M2, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Cir, Toronto M5S 1A1, Canada.
ORCID-Profile: Burton B Yang
Förderung
- Lotte and John Hecht Memorial Foundation
Zitieren
APA
Wu, N., Amalraj, J., & Yang, B. B. (2026). Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation. Precision Clinical Medicine, 9(2). https://doi.org/10.1093/pcmedi/pbag011
Vancouver
Wu N, Amalraj J, Yang BB. Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation. Precision Clinical Medicine. 2026;9(2). doi:10.1093/pcmedi/pbag011
BibTeX
@article{Wu2026,
author = {Wu, Nan and Amalraj, Jeremiah and Yang, Burton B},
title = {Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation},
journal = {Precision Clinical Medicine},
year = {2026},
volume = {9},
number = {2},
doi = {10.1093/pcmedi/pbag011}
}
EUVIMED